These CAR-T BiTE cells have the ability to secrete EGFR-specific BiTEs, which have shown the ability to eliminate heterogeneous tumors in glioblastoma mouse models through recruiting untransduced T cells against wild-type EGFR and redirecting CAR T cells (50). The gene discussed is EGFR; the disease is glioblastoma.